Driscoll Children's Hospital
6
2
2
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
33.3%
2 terminated/withdrawn out of 6 trials
33.3%
-53.2% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
VIGOR: Virtual Genome Center for Infant Health
Role: collaborator
Impact of a Mobile App on Pregnant Women's Prenatal Genetic Testing Decision-making
Role: collaborator
Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology
Role: lead
Performance and Safety Evaluation of the SenSura® Mio Baby Device in Subjects With a Stoma
Role: collaborator
International PPB/DICER1 Registry
Role: collaborator
Post Market Clinical Follow-up Study Evaluating Performance and Safety of the SenSura® Mio Kids Device
Role: collaborator
All 6 trials loaded